Embla Medical Statistics

Total Valuation

Embla Medical has a market cap or net worth of 2.26 billion. The enterprise value is 2.73 billion.

Market Cap	2.26B
Enterprise Value	2.73B

Important Dates

The next estimated earnings date is Tuesday, July 22, 2025.

Earnings Date	Jul 22, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.29%
Shares Change (QoQ)	+4.94%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	160.59M

Valuation Ratios

The trailing PE ratio is 31.31 and the forward PE ratio is 27.31.

PE Ratio	31.31
Forward PE	27.31
PS Ratio	2.63
PB Ratio	2.82
P/TBV Ratio	n/a
P/FCF Ratio	21.20
P/OCF Ratio	17.96
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.83, with an EV/FCF ratio of 25.62.

EV / Earnings	37.84
EV / Sales	2.98
EV / EBITDA	14.83
EV / EBIT	20.64
EV / FCF	25.62

Financial Position

The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.66.

Current Ratio	1.74
Quick Ratio	0.90
Debt / Equity	0.66
Debt / EBITDA	3.13
Debt / FCF	4.96
Interest Coverage	5.36

Financial Efficiency

Return on equity (ROE) is 9.46% and return on invested capital (ROIC) is 5.74%.

Return on Equity (ROE)	9.46%
Return on Assets (ROA)	4.80%
Return on Invested Capital (ROIC)	5.74%
Return on Capital Employed (ROCE)	8.94%
Revenue Per Employee	214,456
Profits Per Employee	18,044
Employee Count	4,061
Asset Turnover	0.55
Inventory Turnover	2.14

Taxes

In the past 12 months, Embla Medical has paid 22.55 million in taxes.

Income Tax	22.55M
Effective Tax Rate	23.68%

Stock Price Statistics

The stock price has decreased by -11.11% in the last 52 weeks. The beta is 0.58, so Embla Medical's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	-11.11%
50-Day Moving Average	4.92
200-Day Moving Average	n/a
Relative Strength Index (RSI)	46.63
Average Volume (20 Days)	587

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Embla Medical had revenue of 857.82 million and earned 72.18 million in profits. Earnings per share was 0.17.

Revenue	857.82M
Gross Profit	542.03M
Operating Income	120.43M
Pretax Income	95.24M
Net Income	72.18M
EBITDA	142.99M
EBIT	120.43M
Earnings Per Share (EPS)	0.17

Full Income Statement

Balance Sheet

The company has 91.77 million in cash and 528.55 million in debt, giving a net cash position of -436.78 million.

Cash & Cash Equivalents	91.77M
Total Debt	528.55M
Net Cash	-436.78M
Net Cash Per Share	n/a
Equity (Book Value)	801.68M
Book Value Per Share	1.87
Working Capital	178.24M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 125.84 million and capital expenditures -19.24 million, giving a free cash flow of 106.60 million.

Operating Cash Flow	125.84M
Capital Expenditures	-19.24M
Free Cash Flow	106.60M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 63.19%, with operating and profit margins of 14.04% and 8.41%.

Gross Margin	63.19%
Operating Margin	14.04%
Pretax Margin	11.10%
Profit Margin	8.41%
EBITDA Margin	16.67%
EBIT Margin	14.04%
FCF Margin	12.43%

Dividends & Yields

Embla Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.29%
Shareholder Yield	n/a
Earnings Yield	3.19%
FCF Yield	4.72%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Embla Medical has an Altman Z-Score of 3.09 and a Piotroski F-Score of 7.

Altman Z-Score	3.09
Piotroski F-Score	7